Christina Soubrane

Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study

Andrew D. Krystal, Milton K. Erman, Gary Zammit et al. · SLEEP · 2008 · 211 citations · Full text

Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomnia

Thomas Roth, Christina Soubrane, Laurence Titeux et al. · Sleep Medicine · 2006 · 117 citations

Sleep Disorders, Sleep, Sleep Disorder +8

A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis

Yannick Allanore, Peter K. Wung, Christina Soubrane et al. · Annals of the Rheumatic Diseases · 2020 · 106 citations · Full text

SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)

Ganesh Raghu, Luca Richeldi, Bruno Crestani et al. · European Respiratory Journal · 2018 · 94 citations · Full text

Controlled Clinical Trial of Zolpidem for the Treatment of Insomnia Associated With Attention-Deficit/ Hyperactivity Disorder in Children 6 to 17 Years of Age

Jeffrey L. Blumer, Robert L. Findling, Weichung Joe Shih et al. · PEDIATRICS · 2009 · 90 citations